Literature DB >> 11640898

Sonic hedgehog is required during an early phase of oligodendrocyte development in mammalian brain.

J A Alberta1, S K Park, J Mora, D Yuk, I Pawlitzky, P Iannarelli, T Vartanian, C D Stiles, D H Rowitch.   

Abstract

Oligodendrocyte precursor development in the embryonic spinal cord is thought to be regulated by the secreted signal, Sonic hedgehog (Shh). Such precursors can be identified by the expression of Olig genes, encoding basic helix-loop-helix factors, in the spinal cord and brain. However, the signaling pathways that govern oligodendrocyte precursor (OLP) development in the rostral central nervous system are poorly understood. Here, we show that Shh is required for oligodendrocyte development in the mouse forebrain and spinal cord, and that Shh proteins are both necessary and sufficient for OLP production in cortical neuroepithelial cultures. Moreover, adenovirus-mediated Olig1 ectopic expression can promote OLP formation independent of Shh activity. Our results demonstrate essential functions for Shh during early phases of oligodendrocyte development in the mammalian central nervous system. They further suggest that a key role of Shh signaling is activation of Olig genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11640898     DOI: 10.1006/mcne.2001.1026

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  27 in total

Review 1.  Sonic hedgehog patterning during cerebellar development.

Authors:  Annarita De Luca; Valentina Cerrato; Elisa Fucà; Elena Parmigiani; Annalisa Buffo; Ketty Leto
Journal:  Cell Mol Life Sci       Date:  2015-10-24       Impact factor: 9.261

2.  Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain.

Authors:  Magdalena A Petryniak; Gregory B Potter; David H Rowitch; John L R Rubenstein
Journal:  Neuron       Date:  2007-08-02       Impact factor: 17.173

3.  Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.

Authors:  Li-Chun Wang; Guillermina Almazan
Journal:  Neurochem Res       Date:  2016-09-17       Impact factor: 3.996

Review 4.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

Review 5.  Cellular and molecular introduction to brain development.

Authors:  Xiangning Jiang; Jeannette Nardelli
Journal:  Neurobiol Dis       Date:  2015-07-13       Impact factor: 5.996

6.  Stage-specific regulation of oligodendrocyte development by Hedgehog signaling in the spinal cord.

Authors:  Xiaofeng Xu; Qian Yu; Minxi Fang; Min Yi; Aifen Yang; Binghua Xie; Junlin Yang; Zunyi Zhang; Zhongmin Dai; Mengsheng Qiu
Journal:  Glia       Date:  2019-10-12       Impact factor: 7.452

7.  High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells.

Authors:  J Fu; S S W Tay; E A Ling; S T Dheen
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

8.  Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain.

Authors:  Miki Furusho; Yoshimi Kaga; Akihiro Ishii; Jean M Hébert; Rashmi Bansal
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

9.  Apotransferrin-induced recovery after hypoxic/ischaemic injury on myelination.

Authors:  Mariano Guardia Clausi; Laura A Pasquini; Eduardo F Soto; Juana M Pasquini
Journal:  ASN Neuro       Date:  2010-11-19       Impact factor: 4.146

10.  NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Authors:  Junsheng Fu; Mariana Rodova; Rajesh Nanta; Daniel Meeker; Peter J Van Veldhuizen; Rakesh K Srivastava; Sharmila Shankar
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.